UTMD

Utah Medical Products Inc.

Price

$68.37

return (12m)

p/e

19.45

p/bv

1.75

DIVIDEND YIELD

1.76%

UTMD price

Utah Medical Products

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment UTMD

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals UTMD

Valuation

P/E

19.45

Sector -2.34

Industry 11.10

P/BV

1.75

Sector 2.17

Industry 3.33

P/Revenue (PSR)

5.62

Sector 2.00

Industry 1.71

EV/EBITDA

33.50

Sector -23.69

Industry -398.52

EV/EBIT

41.07

Sector -36.60

Industry -80.73

P/EBITDA

14.84

Sector -0.10

Industry 8.30

P/EBIT

18.74

Sector -2.08

Industry 5.69

P/Total Assets

1.70

Sector 1.18

Industry 1.57

P/Net Current Assets

2.19

Sector -10.91

Industry -3.38

P/Working Capital

2.18

Sector 0.09

Industry 10.51

EPS

3.62

Sector -0.93

Industry 1.10

BVPS

40.12

Sector 3.87

Industry 14.82

Efficiency

Gross Margin

57.92%

Sector 44.28%

Industry 29.23%

EBITDA Margin

42.32%

Sector -291.45%

Industry 4.29%

EBIT Margin

34.52%

Sector -195.44%

Industry 1.44%

Operating Margin

30.01%

Sector -25.72%

Industry 2.16%

Net Profit Margins

28.92%

Sector -30.19%

Industry 2.77%

Asset Turnover

0.07

Sector 0.12

Industry 0.27

Profitability

ROE

9.01%

Sector -34.71%

Industry 6.97%

ROA

8.72%

Sector -28.76%

Industry 2.97%

ROIC

29.06%

Sector -441.27%

Industry -5.31%

Dividends

Dividend yield

1.76%

Sector -

Industry 0.01%

Payout

34.23%

Sector -

Industry 0.54%

Debt

Current Ratio

28.68

Sector 1.87

Industry 1.51

Net Debt / EBITDA

-23.69

Sector -2.18

Industry -1.68

Net Debt / EBIT

-29.04

Sector -0.74

Industry -7.00

Net Debt / Equity

-0.73

Sector -0.34

Industry 0.05

Gross Debt / Equity

0.00

Sector -0.64

Industry 0.35

Equity/Assets

0.97

Sector 0.43

Industry 0.46

Liabilities/Assets

0.03

Sector 0.46

Industry 0.52

Growth

5Y Revenue CAGR

-5.21%

Sector -

Industry -

5Y Earnings CAGR

-6.01%

Sector -

Industry -

FAIR VALUE OF Utah Medical Products ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$68.37

Fair Value

$57.16

Upside Return potential.

-16.39%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals UTMD

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
UTMD Utah Medical Products Inc.	$68.37	31.60%	1.76%	19.45	1.75	9.01%	28.92%
EW Edwards Lifesciences Corp.	$78.21	12.69%	0.00%	45.55	4.82	10.58%	17.34%
BSX Boston Scientific Corp.	$63.80	-31.89%	0.00%	18.45	2.54	13.78%	17.29%
ABT Abbott Laboratories	$101.06	-18.35%	0.00%	25.64	3.09	12.06%	13.91%
ABMD Abiomed Inc.	$0.00	-	0.00%	64.27	11.14	17.32%	24.84%
ALGN Align Technology Inc.	$184.69	12.52%	0.00%	27.86	2.89	10.36%	10.50%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

UTMD Historical Dividends

current DY: 1.76%

5-year average DY: 2.00%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	03/17/2026	04/03/2026	0.31000000
Dividends	12/16/2025	01/05/2026	0.31000000
Dividends	09/17/2025	10/02/2025	0.30500000
Dividends	06/16/2025	07/03/2025	0.30500000
Dividends	03/14/2025	04/03/2025	0.30500000
Dividends	12/16/2024	01/03/2025	0.30500000
Dividends	09/20/2024	10/04/2024	0.30000000
Dividends	06/14/2024	07/05/2024	0.30000000
Dividends	03/15/2024	04/03/2024	0.30000000
Dividends	12/15/2023	01/03/2024	0.30000000
Dividends	09/15/2023	10/03/2023	0.29500000
Dividends	06/16/2023	07/06/2023	0.29500000
Dividends	03/17/2023	04/04/2023	0.29500000
Dividends	12/16/2022	01/04/2023	0.29500000
Dividends	09/16/2022	10/05/2022	0.29000000
Dividends	06/17/2022	07/06/2022	0.29000000
Dividends	03/18/2022	04/05/2022	0.29000000
Dividends	12/15/2021	12/29/2021	2.00000000
Dividends	09/16/2021	10/05/2021	0.28500000
Dividends	06/15/2021	07/06/2021	0.28500000
Dividends	03/17/2021	04/02/2021	0.28500000
Dividends	12/15/2020	01/05/2021	0.28500000
Dividends	09/15/2020	10/05/2020	0.28000000
Dividends	06/17/2020	07/03/2020	0.28000000
Dividends	03/13/2020	04/02/2020	0.28000000
Dividends	12/13/2019	01/03/2020	0.28000000
Dividends	09/13/2019	10/03/2019	0.27500000
Dividends	06/14/2019	07/03/2019	0.27500000
Dividends	03/15/2019	04/02/2019	0.27500000
Dividends	12/14/2018	01/03/2019	0.27500000
Dividends	09/14/2018	10/02/2018	0.27000000
Dividends	06/15/2018	07/06/2018	0.27000000
Dividends	03/16/2018	04/03/2018	0.27000000
Dividends	12/15/2017	01/03/2018	0.27000000
Dividends	09/15/2017	10/03/2017	0.26500000
Dividends	06/16/2017	07/06/2017	0.26500000
Dividends	03/17/2017	04/04/2017	0.26500000
Dividends	12/16/2016	12/30/2016	0.26500000
Dividends	09/16/2016	10/04/2016	0.26000000
Dividends	06/17/2016	07/06/2016	0.26000000
Dividends	03/18/2016	04/06/2016	0.26000000
Dividends	12/16/2015	12/30/2015	0.26000000
Dividends	09/18/2015	10/02/2015	0.25500000
Dividends	06/19/2015	07/02/2015	0.25500000
Dividends	03/18/2015	04/02/2015	0.25500000
Dividends	12/16/2014	12/30/2014	0.25500000
Dividends	09/18/2014	10/02/2014	0.25000000
Dividends	06/18/2014	07/03/2014	0.25000000
Dividends	03/18/2014	04/02/2014	0.25000000
Dividends	12/16/2013	12/30/2013	0.25000000
Dividends	09/16/2013	10/04/2013	0.24500000
Dividends	06/14/2013	07/03/2013	0.24500000
Dividends	03/19/2013	04/04/2013	0.24500000
Dividends	12/13/2012	12/28/2012	0.24500000
Dividends	09/14/2012	10/04/2012	0.24000000
Dividends	06/15/2012	07/05/2012	0.24000000
Dividends	03/19/2012	04/04/2012	0.24000000
Dividends	12/14/2011	12/29/2011	0.24000000
Dividends	09/16/2011	10/05/2011	0.23500000
Dividends	06/17/2011	07/05/2011	0.23500000
Dividends	03/18/2011	04/05/2011	0.23500000
Dividends	12/15/2010	12/30/2010	0.96000000
Dividends	09/16/2010	10/05/2010	0.22720000
Dividends	06/15/2010	07/02/2010	0.22720000
Dividends	03/12/2010	04/02/2010	0.22720000
Dividends	12/16/2009	12/30/2009	0.22720000
Dividends	09/16/2009	10/05/2009	0.22240000
Dividends	06/16/2009	07/06/2009	0.22240000
Dividends	03/13/2009	04/03/2009	0.22240000
Dividends	12/16/2008	12/30/2008	0.22240000
Dividends	09/15/2008	10/03/2008	0.21750000
Dividends	06/16/2008	07/03/2008	0.21750000
Dividends	03/14/2008	04/03/2008	0.21750000
Dividends	12/14/2007	01/03/2008	0.21750000
Dividends	09/14/2007	10/03/2007	0.21270000
Dividends	06/15/2007	07/05/2007	0.21270000
Dividends	03/15/2007	04/04/2007	0.21270000
Dividends	12/14/2006	01/04/2007	0.20300000
Dividends	09/15/2006	10/04/2006	0.19340000
Dividends	06/16/2006	07/05/2006	0.18370000
Dividends	03/16/2006	04/05/2006	0.17400000
Dividends	12/16/2005	01/05/2006	0.16440000
Dividends	09/16/2005	10/05/2005	0.14990000
Dividends	06/17/2005	07/05/2005	0.14990000
Dividends	03/16/2005	04/05/2005	0.14500000
Dividends	12/16/2004	01/05/2005	0.14500000
Dividends	09/16/2004	10/05/2004	0.14500000
Dividends	06/16/2004	07/05/2004	0.14500000
Dividends	11/04/1993	11/10/1993	0.01930000
Dividends	08/19/1993	08/30/1993	0.01930000
Dividends	04/27/1993	05/07/1993	0.01930000

ABOUT Utah Medical Products

Utah Medical Products Inc.

Average Investor10 user rating

4.0 (0 people)

States of America

48 years

Founded: 1978

1999

Time since IPO - 27 years

224

Employees

Utah Medical Products Inc. (States of America) is listed on the Nasdaq and has a market capitalization of $211.02 million, with shareholders equity totaling $120.37 million.

The company employs approximately 224 people and operates in the Saúde sector, within the Materiais e Equipamentos Médicos industry.

Over the past 12 months, Utah Medical Products Inc. reported $37.52 million in revenue, generating net income of $10.85 million.

Key financial metrics include a P/E ratio of 19.45, a price-to-book (P/B) ratio of 1.75, and a trailing twelve-month dividend yield of 1.76%.

The company trades under the ticker UTMD.

Market cap

$211.02 million

Net worth

$120.37 million

$120,370,000.00

Assets

$124.38 million

$124,380,000.00

Total Shares Outstanding

3.00 million

3,000,000

Average Daily Trading Volume

$14.15 Thousand

$14,153.20

Sector

Saúde

Industry

Materiais e Equipamentos Médicos

UTMD

UTMD revenue and profits

Financial Results UTMD

DRAG THE FRAME TO SEE MORE DATA

UTMD cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$77.63 34,88% (12M)

P/E

46.88

2.46%

ROE

3.78%

P/BV

1.77

CI - Cigna

$272.65 --5,23% (12M)

P/E

11.58

2.16%

ROE

15.39%

P/BV

1.78

CNC - Centene

$37.26 38,72% (12M)

P/E

-4.98

0.00%

ROE

-29.93%

P/BV

1.49

HUM - Humana

$196.30 --14,19% (12M)

P/E

42.07

0.89%

ROE

6.06%

P/BV

2.55

SNY - Sanofi

$47.64 --3,72% (12M)

P/E

7.21

4.00%

ROE

17.79%

P/BV

1.28

LLY - Eli Lilly

$923.03 21,62% (12M)

P/E

41.74

0.55%

ROE

81.02%

P/BV

33.82

HCA - HCA Healthcare

$498.78 47,18% (12M)

P/E

12.41

0.80%

ROE

-228.14%

P/BV

-28.31

NVS - Novartis

$153.41 34,63% (12M)

P/E

21.74

2.01%

ROE

34.77%

P/BV

7.56